Novel Targetable BIOmarkers in ANorexia NervosA
Recruiting
Observational Study
Anorexia Nervosa
Anorexia Nervosa Restricting Type
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 60
- Sex
- Any
- Study type
- Observational
- Participants needed
- 32 (estimated)
- Sponsor
- University Hospital, Basel, Switzerland · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The overall aim of this present study is to evaluate Growth Differentiation Factor-15 (GDF-15) and inflammatory cytokines as a possible novel and readily treatable target for the successful therapy of Anorexia Nervosa (AN). Therefore, GDF-15, neuronal and glial damage markers such as Neurofilament light chain (Nfl) and Glial fibrillary acidic protein (GFAP) and cytokines (such as Tumor necrosis fa…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
N=8 adult male and female patients with confirmed diagnosis of anorexia nervosa restrictive type, non-exercising subtype
Inclusion criteria:
* Age 18-60 years
* Written informed consent
* BMI 10-16 kg/m2
N=8 adult male and female patients with confirmed diagnosis of anorexia nervosa restrictive t…
Contacts